£56k
−76%vs Mar 2024Active09970031Private limited companyLondon
CURADEV PHARMA LIMITED
Significant control: Arjun Surya (50–75%), Manish Tandon (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Curadev Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Curadev Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CURADEV PHARMA LIMITED is an active private limited company (company number 09970031) incorporated on 26 January 2016, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of £56k and cash of £101k, with 3 employees on average. Net assets fell 76% on the prior period (£229k).
Peer position · net assets
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mr Arjun Surya
- owns 50–75% of shares
- holds 50–75% of voting rights
- Mr Manish Tandon
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 January 201610 yrs ago
- Next accounts due
- 31 December 2026in 67 days
- Confirmation statement due
- 9 February 2027in 107 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£101k
−53%vs Mar 2024Not reported
3
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £56k | £101k | — | £55k | — | — | 3 |
| 31 March 2024 | £229k | £215k | — | £54k | — | — | 3 |
Current ratio2.01Current assets ÷ creditors within one year
Cash per employee£34kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £55,862 at 31 March 2025
- Net assets down 25% or more on the prior period-75.6% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.01
- Cash at bank of £50,000 or moreCash £101,182
- Incorporated five or more years agoIncorporated 26 January 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 107 days
- Next accounts duein 67 days
- Accounts period endNet assets £56k · small accounts
- Accounts period endNet assets £229k · small accounts
- Incorporated
08
Similar companies in London
- NATURE TERMS LABORATORY LIMITEDLondon · inc. Dec 2015
- VORN GROUP LIMITEDLondon · inc. Mar 2016
- CIDARA THERAPEUTICS UK LIMITEDLondon · inc. Mar 2016
- OWS AGRI LTDLondon · inc. Mar 2016
- BLUEBIRD BIO (UK) LTD.London · inc. Mar 2016
- 3P SENSE LIMITEDLondon · inc. Mar 2016
All companies incorporated on 26 January 2016 · in Jan 2016.
09
Reminders for CURADEV PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.